{"id":"https://openalex.org/W4412379065","doi":"https://doi.org/10.3389/fonc.2025.1607955","title":"Concerns and recommendations: antiplatelet agents and cancer prevention in non-alcoholic fatty liver disease","display_name":"Concerns and recommendations: antiplatelet agents and cancer prevention in non-alcoholic fatty liver disease","publication_year":2025,"publication_date":"2025-07-14","ids":{"openalex":"https://openalex.org/W4412379065","doi":"https://doi.org/10.3389/fonc.2025.1607955","pmid":"https://pubmed.ncbi.nlm.nih.gov/40727477"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2025.1607955","doi":"https://doi.org/10.3389/fonc.2025.1607955","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2025.1607955","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1607955/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1607955/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028983260","display_name":"Hong Tham Pham","orcid":"https://orcid.org/0000-0002-2366-629X","observed_orcids":["https://orcid.org/0000-0002-2366-629X"]},"institutions":[{"id":"https://openalex.org/I3020192730","display_name":"Tr\u01b0\u1eddng \u0110H Nguy\u1ec5n T\u1ea5t Th\u00e0nh","ror":"https://ror.org/04r9s1v23","country_code":"VN","type":"education","lineage":["https://openalex.org/I3020192730"]}],"countries":["VN"],"is_corresponding":false,"raw_author_name":"Hong Tham Pham","raw_affiliation_strings":["Faculty of Pharmacy, Nguyen Tat Thanh University, Ho Chi Minh,\u00a0Vietnam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Nguyen Tat Thanh University, Ho Chi Minh,\u00a0Vietnam","institution_ids":["https://openalex.org/I3020192730"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093639042","display_name":"Kim\u2010Huong Truong\u2010Nguyen","orcid":"https://orcid.org/0009-0004-6503-2756","observed_orcids":["https://orcid.org/0009-0004-6503-2756"]},"institutions":[{"id":"https://openalex.org/I4405267813","display_name":"B\u1ec7nh vi\u1ec7n Nh\u00e2n d\u00e2n Gia \u0110\u1ecbnh","ror":"https://ror.org/04ghved39","country_code":"VN","type":"healthcare","lineage":["https://openalex.org/I4405267813"]}],"countries":["VN"],"is_corresponding":false,"raw_author_name":"Kim-Huong Truong-Nguyen","raw_affiliation_strings":["Department of Pharmacy, Nhan Dan Gia Dinh Hospital, Ho Chi Minh,\u00a0Vietnam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Nhan Dan Gia Dinh Hospital, Ho Chi Minh,\u00a0Vietnam","institution_ids":["https://openalex.org/I4405267813"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062257756","display_name":"Minh\u2010Hoang Tran","orcid":"https://orcid.org/0000-0003-1351-8442","observed_orcids":["https://orcid.org/0000-0003-1351-8442"]},"institutions":[{"id":"https://openalex.org/I3020192730","display_name":"Tr\u01b0\u1eddng \u0110H Nguy\u1ec5n T\u1ea5t Th\u00e0nh","ror":"https://ror.org/04r9s1v23","country_code":"VN","type":"education","lineage":["https://openalex.org/I3020192730"]}],"countries":["VN"],"is_corresponding":true,"raw_author_name":"Minh-Hoang Tran","raw_affiliation_strings":["NTT Hi-Tech Institute, Nguyen Tat Thanh University, Ho Chi Minh,\u00a0Vietnam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NTT Hi-Tech Institute, Nguyen Tat Thanh University, Ho Chi Minh,\u00a0Vietnam","institution_ids":["https://openalex.org/I3020192730"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5062257756"],"corresponding_institution_ids":["https://openalex.org/I3020192730"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.15726254,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":null,"first_page":"1607955","last_page":"1607955"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.6782000064849854,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.6782000064849854,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.17309999465942383,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.04670000076293945,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiplatelet-drugs","display_name":"antiplatelet agents","score":0.949999988079071},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.9620000123977661},{"id":"https://openalex.org/keywords/cancer-prevention","display_name":"cancer prevention","score":0.7929999828338623},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9210000038146973},{"id":"https://openalex.org/keywords/confounding-by-indication","display_name":"confounding by indication","score":0.7839999794960022},{"id":"https://openalex.org/keywords/immortal-time-bias","display_name":"immortal time bias","score":0.9049999713897705},{"id":"https://openalex.org/keywords/landmark-analysis","display_name":"landmark analysis","score":0.8240000009536743},{"id":"https://openalex.org/keywords/follow-up-duration","display_name":"follow-up duration","score":0.6320000290870667},{"id":"https://openalex.org/keywords/non-alcoholic-cirrhosis","display_name":"non-alcoholic cirrhosis","score":0.7689999938011169},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.6190000176429749},{"id":"https://openalex.org/keywords/chemoprotection","display_name":"chemoprotection","score":0.6330000162124634},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.39500001072883606},{"id":"https://openalex.org/keywords/study-design-critique","display_name":"study design critique","score":0.48399999737739563},{"id":"https://openalex.org/keywords/statistical-analysis-critique","display_name":"statistical analysis critique","score":0.44200000166893005},{"id":"https://openalex.org/keywords/cancer-incidence","display_name":"cancer incidence","score":0.44600000977516174}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7022214531898499},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.6794300675392151},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6362690329551697},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5365374684333801},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4585449993610382},{"id":"https://openalex.org/C2777575235","wikidata":"https://www.wikidata.org/wiki/Q558404","display_name":"Alcoholic liver disease","level":3,"score":0.41238734126091003},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.4123713970184326},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3725125789642334},{"id":"https://openalex.org/C2777214474","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Cirrhosis","level":2,"score":0.190189391374588}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2025.1607955","doi":"https://doi.org/10.3389/fonc.2025.1607955","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2025.1607955","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1607955/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:40727477","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40727477","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12301193","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12301193","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:b23b035e2a304a4e816cc6c0f190e02b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b23b035e2a304a4e816cc6c0f190e02b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 15 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2025.1607955","doi":"https://doi.org/10.3389/fonc.2025.1607955","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2025.1607955","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1607955/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7799999713897705}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4412379065.pdf","grobid_xml":"https://content.openalex.org/works/W4412379065.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1982458364","https://openalex.org/W2038981426","https://openalex.org/W2161515661","https://openalex.org/W2492495737","https://openalex.org/W2527032421","https://openalex.org/W2887965899","https://openalex.org/W2910632137","https://openalex.org/W2997876558","https://openalex.org/W4244424204","https://openalex.org/W4401975629","https://openalex.org/W4402364284","https://openalex.org/W4404967788","https://openalex.org/W4406224565"],"related_works":["https://openalex.org/W124733979","https://openalex.org/W1889629264","https://openalex.org/W2072631600","https://openalex.org/W2143014395","https://openalex.org/W2126278804","https://openalex.org/W4382918553","https://openalex.org/W1979895878","https://openalex.org/W2181745077","https://openalex.org/W3132255551","https://openalex.org/W4303648544"],"abstract_inverted_index":{"The":[0,152,429],"study":[1,107,616],"entitled":[2],"\"The":[3],"chemoprotective":[4],"effect":[5],"of":[6,47,63,91,100,132,159,169,189,258,298,348,355,372,382,484,489,575,594,617],"anti-platelet":[7],"agents":[8,38,102],"on":[9,338,559],"cancer":[10,40,485,490],"incidence":[11,41],"in":[12,25,42,139,195,224,414,467,473,542,603],"people":[13,656],"with":[14,226,269,304,390,577,664],"nonalcoholic":[15],"fatty":[16,670],"liver":[17,671],"disease":[18,672],"(NAFLD):":[19],"a":[20,323,339,380,399,650],"retrospective":[21],"cohort":[22],"study,\"":[23],"published":[24],"the":[26,33,45,56,89,96,106,109,117,128,178,187,213,245,255,263,315,319,328,346,353,366,370,373,426,433,436,443,464,468,482,487,519,565,588,592,621,626,637],"BMC":[27],"Medicine":[28],"[1],provides":[29],"novel":[30],"insights":[31,549],"into":[32],"potential":[34,449],"link":[35],"between":[36,180,435,639,652],"antiplatelet":[37,101,121,133,160,259],"and":[39,61,94,130,183,308,438,527,553,568,660],"NAFLD,":[43,299],"underscoring":[44],"importance":[46],"further":[48],"research.":[49],"Nevertheless,":[50],"we":[51,198,496],"have":[52,173,266],"several":[53],"concerns":[54],"regarding":[55],"study's":[57],"design,":[58,108],"statistical":[59,316,340],"approach,":[60,197,401],"interpretation":[62],"findings":[64,413,561],"that":[65,144,240,385,421,511,539],"were":[66,641,657],"not":[67,79,113,136,163,278,335,387,441,536,581,624],"adequately":[68,114],"addressed.":[69],"These":[70],"issues":[71],"are":[72,296,301,534,632],"likely":[73,302,658],"to":[74,87,177,208,218,250,253,311,326,454,550,584,634,644],"challenge":[75],"other":[76,206,499],"investigators":[77],"if":[78],"being":[80],"awared":[81],"of.":[82],"We":[83,242,396],"provide":[84],"some":[85],"recommendations":[86],"strengthen":[88],"robustness":[90],"future":[92,415],"studies":[93,417,533],"identify":[95],"underlying":[97],"protective":[98],"mechanisms":[99],"outside":[103],"cardiovascular":[104,181],"areas.For":[105],"original":[110,264,320],"authors":[111,265,321,622],"did":[112,277,623],"adjust":[115],"for":[116,119,154,221,231,280,410,448,463,596,609,628],"reasons/indications":[118],"prescribing":[120],"agents.":[122,260],"Cardiovascular":[123],"risk,":[124],"which":[125,235,631],"usually":[126,236,535],"determines":[127],"choice":[129],"duration":[131],"therapy,":[134],"was":[135,162],"comprehensively":[137],"measured":[138],"this":[140,196,210,332,474,494,585,615],"study.":[141],"This":[142],"implies":[143],"confounding":[145,424],"by":[146,477],"indication":[147],"may":[148,171,480],"still":[149,172,547],"be":[150,219,379,388,452,524,601,662],"present.":[151],"cut-off":[153],"exposure":[155],"classification":[156],"(\u22651":[157],"year":[158],"therapy)":[161],"well":[164],"justified,":[165],"as":[166,358,403,502,516],"shorter":[167,305],"durations":[168],"use":[170],"clinical":[174,543],"relevance":[175],"due":[176,643],"connection":[179],"diseases":[182],"cancers":[184,223],"[2].":[185],"Given":[186],"risk":[188,381,514],"introducing":[190],"selection":[191],"or":[192,204,274,286,291,407,446,486,507,556,611,654],"measurement":[193],"bias":[194],"suggest":[199,243,397,497],"predefining":[200],"an":[201],"evidence-based":[202],"threshold":[203],"exploring":[205],"cut-offs":[207],"avoid":[209,312,455],"issue.":[211],"Additionally,":[212,368],"5-year":[214,374],"follow-up":[215,246,375],"period":[216],"seemed":[217],"insufficient":[220],"detecting":[222],"patients":[225,268,361],"unknown":[227,478],"genetic":[228],"risks,":[229],"particularly":[230],"hepatocellular":[232,666],"carcinoma":[233,667],"(HCC),":[234],"takes":[237],"longer":[238],"than":[239],"[3].":[241],"increasing":[244],"duration,":[247,376],"e.g.,":[248,284],"up":[249],"10":[251],"years,":[252],"investigate":[254],"long-term":[256],"effects":[257],"Noteworthily,":[261],"while":[262,318],"excluded":[267],"non-alcoholic":[270,669],"cirrhosis":[271],"(ICD-10":[272,288],"K70.2":[273],"K70.3),":[275],"they":[276,300,546],"account":[279,462],"its":[281],"earlier":[282],"stages,":[283],"fibrosis":[285],"sclerosis":[287],"K74.0,":[289],"K74.1,":[290],"K74.2).":[292],"As":[293],"these":[294,560],"conditions":[295],"complications":[297],"associated":[303],"time-to-HCC":[306],"events":[307,364],"need":[309],"adjusting":[310,447],"confounded":[313],"findings.For":[314],"analysis,":[317,579],"used":[322],"landmark":[324],"analysis":[325,344],"manage":[327],"immortal":[329,349],"time":[330,350],"bias,":[331],"approach":[333],"is":[334,425,587],"efficient":[336],"based":[337,558],"perspective":[341],"[4,5].":[342],"Landmark":[343],"mitigates":[345],"misclassification":[347],"but":[351],"at":[352,369],"cost":[354],"decreased":[356],"power,":[357],"it":[359],"excludes":[360],"who":[362],"experience":[363],"before":[365],"landmark.":[367],"end":[371],"there":[377],"might":[378],"covariate":[383],"imbalance":[384],"could":[386,422,600],"controlled":[389],"propensity":[391,674],"score":[392,675],"matching":[393,676],"(PSM)":[394],"[6].":[395],"using":[398,498],"time-dependent":[400,404],"such":[402,501],"Cox":[405],"regression":[406],"g":[408],"methods,":[409,500],"more":[411],"robust":[412],"observational":[416,532],"[7,8].":[418],"Another":[419],"issue":[420],"introduce":[423],"subgroup":[427,521,578],"analysis.":[428,470],"PSM":[430],"only":[431],"ensured":[432],"balance":[434],"exposed":[437],"unexposed":[439],"groups,":[440],"within":[442],"subgroups.":[444],"Rematching":[445],"confounders":[450],"should":[451,460,661],"considered":[453],"biased":[456],"estimates.":[457],"Future":[458],"investigations":[459],"also":[461],"competing":[465],"risks":[466],"survival":[469],"For":[471],"example,":[472],"case,":[475],"death":[476],"causes":[479],"preclude":[481],"occurrence":[483],"detection":[488],"outcomes.":[491],"To":[492],"address":[493],"issue,":[495],"Fine-Gray":[503],"subdistribution":[504],"hazard":[505,509],"model":[506],"causespecific":[508],"models":[510],"include":[512],"common":[513],"factors":[515],"covariates":[517],"[9,10].For":[518],"interpretation/reporting,":[520],"analysis-if":[522],"used-should":[523],"thoroughly":[525],"reported":[526],"interpreted.Although":[528],"subgroup/stratified":[529],"results":[530],"from":[531],"golden":[537],"evidence":[538],"warrants":[540],"changes":[541],"settings":[544],"[11],":[545],"implicate":[548],"both":[551],"expert":[552],"non-expert":[554],"readers.Overconclusion":[555],"misinterpretation":[557],"can":[562],"easily":[563],"mislead":[564],"general":[566],"readers":[567],"stimulate":[569],"unconfirmed":[570],"practices.":[571],"A":[572],"well-known":[573],"example":[574],"problems":[576],"although":[580],"necessarily":[582],"relevant":[583],"study,":[586],"ISIS-2":[589],"trial,":[590],"where":[591],"benefits":[593],"aspirin":[595],"acute":[597],"myocardial":[598],"infarction":[599],"seen":[602],"all":[604],"astrological":[605],"birth":[606],"signs":[607],"except":[608],"Libra":[610],"Gemini":[612],"[12].":[613],"In":[614],"Anson":[618],"et":[619],"al.,":[620],"report":[625],"p-values":[627],"interaction":[629],"[1],":[630],"needed":[633],"determine":[635],"whether":[636],"differences":[638],"subgroups":[640],"highly":[642],"chance.":[645],"Thus,":[646],"any":[647],"interpretations":[648],"implying":[649],"difference":[651],"males/females":[653],"older/younger":[655],"overstating":[659],"treated":[663],"caution.HCC:":[665],"NAFLD:":[668],"PSM:":[673]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2025-10-10T00:00:00"}